biostudies-literatureUnknown14(3)Osborne A<h4>Objective</h4>This study examined the prevalence of amphetamine use and its associated factors among in-school adolescents in Sierra Leone.<h4>Design</h4>Data for the study was sourced from the 2017 Sierra Leone Global School-based Health Survey. Percentages with confidence intervals (CIs) were used to present the prevalence of amphetamine use among in-school adolescents. A multivariable binary logistic regression analysis was employed to examine the factors associated with amphetamine use. The results were presented using adjusted odds ratios (aORs) with 95% CIs.<h4>Setting</h4>Sierra Leone.<h4>Participants</h4>A weighted sample of 1,314 in-school adolescents in Sierra Leone.<h4>Outcome measure</h4>Lifetime amphetamine use.<h4>Results</h4>The prevalence of amphetamine use was 6.1% (3.BMJ opene080225https://www.ebi.ac.uk/biostudies/studies/S-EPMC10936465biostudies-literaturePrevalence and predictors of lifetime amphetamine use among in-school adolescents in Sierra Leone.PMC10936465Osborne ABangura CSeidu AAAboagye RGJames PBKangbai JBOlorunsaiye CZAhinkorah BOfalsePrevalence and predictors of lifetime amphetamine use among in-school adolescents in Sierra Leone.<h4>Objective</h4>This study examined the prevalence of amphetamine use and its associated factors among in-school adolescents in Sierra Leone.<h4>Design</h4>Data for the study was sourced from the 2017 Sierra Leone Global School-based Health Survey. Percentages with confidence intervals (CIs) were used to present the prevalence of amphetamine use among in-school adolescents. A multivariable binary logistic regression analysis was employed to examine the factors associated with amphetamine use. The results were presented using adjusted odds ratios (aORs) with 95% CIs.<h4>Setting</h4>Sierra Leone.<h4>Participants</h4>A weighted sample of 1,314 in-school adolescents in Sierra Leone.<h4>Outcome measure</h4>Lifetime amphetamine use.<h4>Results</h4>The prevalence of amphetamine use was 6.1% (3.2024-01-01T00:00:00Z2024 Mar2026-07-15T00:44:47.767Z2026-06-27T03:06:15.388ZS-EPMC109364653847169210.1136/bmjopen-2023-080225